NABI would be mad to not support the merger. My question remains. What happens if biota's price moves significantly upwards ahead of the deal?
Biota is in quite a unique position. Think about it. They are looking to self-market to the stockpiling market for global Laninamivir!!!! What royalty will they pay daichi sankyo? 4-6% + milestones?
The pipeline is about to go through massive inflection points. This will excite US analysts and investment funds. Sooner the merger happens the better.
Another question. Do you buy NABI directly for cheaper exposure? I prefer biota in case of takeover. But that's just me.
I so wish bonus season was sooner.
BTA Price at posting:
85.0¢ Sentiment: Buy Disclosure: Held
